MicroRNA 1273g: A promising drug target and biomarker (G100616145)

Target Name: MicroRNA 1273g

NCBI ID: G100616145

MicroRNA 1273g

Other Name(s): MIR1273G

MicroRNA 1273g: A promising drug target and biomarker

MicroRNAs (miRNAs) are short non-coding RNAs that play a crucial role in post-transcriptional gene regulation. They are estimated to be around 20-22nt in length and are expressed in high levels in various cell types. One of the well-known miRNAs is MicroRNA 1273g.

MicroRNA 1273g is a non-coding RNA molecule that is approximately 19.4nt in length. It is expressed in various cell types and is highly conserved across different species. The miRNA 1273g gene has a strong positive correlation with the protein known as GLUT1, which is a well-known glucose transporter.

The GLUT1 protein is an important drug target and has been extensively studied as a potential drug for various diseases, including diabetes, cancer, and neurodegenerative diseases. GLUT1 has been shown to play a role in regulating various cellular processes, including cell growth, apoptosis, and angiogenesis.

MicroRNA 1273g has been shown to be highly expressed in various tissues and cells, including the brain, heart, liver, and pancreas. It has also been shown to be involved in the regulation of cellular processes that are relevant to many diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

One of the promising aspects of MicroRNA 1273g is its potential as a drug target. The conservation of the GLUT1 gene and the fact that MicroRNA 1273g is highly expressed in GLUT1-positive cells make it an attractive candidate for drug targeting. Additionally, the fact that GLUT1 is involved in many cellular processes that are crucial for human health and disease suggests that targeting GLUT1 may have potential therapeutic benefits.

MicroRNA 1273g has also been shown to be a potential biomarker for various diseases. The high expression of MicroRNA 1273g in various tissues and cells suggests that it may be a useful biomarker for diseases associated with GLUT1 dysfunction, such as diabetes, cancer, and neurodegenerative diseases.

In conclusion, MicroRNA 1273g is a promising drug target and biomarker. Its conservation in GLUT1-positive cells and its involvement in various cellular processes that are relevant to many diseases make it an attractive candidate for drug targeting. Further research is needed to fully understand the role of MicroRNA 1273g in disease and to develop safe and effective drugs that target it.

Protein Name: MicroRNA 1273g

The "MicroRNA 1273g Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MicroRNA 1273g comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets